AFFINI-T THERAPEUTICS
Company Overview
Social Media Profiles
About Affini-T Therapeutics
Description
Affini-T Therapeutics specializes in harnessing T cell therapies combined with CRISPR gene editing to target oncogenic drivers like KRAS. The company focuses on innovative solutions in the Biotechnology and Life Sciences sectors, aiming to unlock the potential of the immune system in cancer treatment.
Specialties
TCR-based immunotherapies
CRISPR gene editing
Targeting oncogenic drivers
Solid tumor treatments
Innovative cancer solutions
Products & Services
TCR-based immunotherapies
CRISPR gene editing
Oncogenic driver targeting
Solid tumor treatments
Biotechnology solutions
Contact Information
Email Addresses
Competitors & Similar Companies(10)
Editas Medicine
Massachusetts, • United States
Bluebird Bio
Massachusetts, • United States
CRISPR Therapeutics
Massachusetts, • United States
Celyad Oncology
Beam Therapeutics
Massachusetts, • United States
Intellia Therapeutics
Massachusetts, • United States
Zymeworks
British Columbia, • Canada
Syndax Pharmaceuticals
Massachusetts, • United States
Junshi Biosciences
Adaptimmune Therapeutics
Pennsylvania, • United States
News & Media
Search Terms:
affini-t therapeutics
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Frequently Asked Questions about Affini-T Therapeutics
Where is Affini-T Therapeutics located?
The headquarter of Affini-T Therapeutics is located in Watertown, Massachusetts, United States
What is the email address of Affini-T Therapeutics?
The email addresses of Affini-T Therapeutics are [email protected]
What is the official website of Affini-T Therapeutics?
The official website of Affini-T Therapeutics is https://www.affinittx.com
What industry does Affini-T Therapeutics belong to?
Affini-T Therapeutics belongs to the Biotechnology, Data Analytics and Business Intelligence, Biotechnology and Life Sciences industry.
What are the specialties of Affini-T Therapeutics?
Affini-T Therapeutics specializes in TCR-based immunotherapies, CRISPR gene editing, Targeting oncogenic drivers, Solid tumor treatments, Innovative cancer solutions.
What products and services is Affini-T Therapeutics likely to offer?
Affini-T Therapeutics offers TCR-based immunotherapies, CRISPR gene editing, Oncogenic driver targeting, Solid tumor treatments, Biotechnology solutions.
Who are the competitors of Affini-T Therapeutics?
Competitors of Affini-T Therapeutics are Editas Medicine, Bluebird Bio, CRISPR Therapeutics, Celyad Oncology, Beam Therapeutics, Intellia Therapeutics, Zymeworks, Syndax Pharmaceuticals, Junshi Biosciences, Adaptimmune Therapeutics.
What does Affini-T Therapeutics do?
Affini-T Therapeutics specializes in harnessing T cell therapies combined with CRISPR gene editing to target oncogenic drivers like KRAS. The company focuses on innovative solutions in the Biotechnology and Life Sciences sectors, aiming to unlock the potential of the immune system in cancer treatment.